Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Actas Dermo-Sifiliograficas|June 13, 2022
Oral Lesions in Patients With Psoriasis: Prevalence and Association With Its Clinical and Epidemiological CharacteristicsA Altemir, G Melé-Ninot, A I Lázaro-Simó, et al.
Actas Dermo-Sifiliograficas|March 2, 2025
Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter StudyJ Ceravalls, A M Giménez-Arnau, V Expósito-Serrano, et al.
Actas Dermo-Sifiliograficas|May 22, 2025
Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter StudyJ Ceravalls, A M Giménez-Arnau, V Expósito-Serrano, et al.
Actas Dermo-Sifiliograficas|August 16, 2018
Algorithm for Treatment of Chronic Spontaneous Urticaria with OmalizumabJ Spertino, L Curto Barredo, E Rozas Muñoz, et al.
Actas Dermo-Sifiliograficas|April 22, 2024
[Translated article] Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC)J Verdaguer-Faja, L Borrego, P Mercader-García, et al.
Actas Dermo-Sifiliograficas|October 11, 2025
[Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?C P Hernández Fernández, L Borrego, A M Giménez Arnau, et al.
Actas Dermo-Sifiliograficas|March 2, 2025
Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series?C P Hernández Fernández, L Borrego, A M Giménez Arnau, et al.
Actas Dermo-Sifiliograficas|June 1, 2024
[Translated article] Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)F J Navarro-Triviño, L Borrego, J F Silvestre-Salvador, et al.
Pageof 1